Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension

ASAIO Journal

Volumn 51, Issue 4, 2005, Pages 456-460

  Haddad, Haissam ^a   Elabbassi, Wael ^a   Moustafa, Sherif ^a   Davies, Ross ^a   Mesana, Thierry ^a   Hendry, Paul ^a   Masters, Roy ^a   Mussivand, Tofy ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CARDIOVASCULAR SURGERY; MEDICAL PROBLEMS; PULMONARY DISEASES; RESPIRATORY SYSTEM; TRANSPLANTS;

CARDIAC TRANSPLANTATION; HEART FAILURE; LEFT VENTRICULAR ASSIST DEVICE (LVAD); PULMONARY HYPERTENSION;

PROSTHETICS;

CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG SAFETY; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 23044501881     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000169125.21268.d7     Document Type: Review

References (34)

1. Smith ER: Heart failure-are we making progress? Can J Cardiol 18: 1124-1125, 2002.
2. Leeman M, Van Cutsem M, Vachiery JL, et al: Determinants of right ventricular failure after heart transplantation. Acta Cardiol 51: 441-449, 1996.
3. Campana C, Gavazzi A, Marioni R, et al: Right ventricular failure after heart transplantation: Relationship with preoperative hemodynamic parameters. Transpl Int 5: S221-S223, 1992.
4. Abramson SV, Burke JF, Kelly JJ Jr, et al: Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116: 888-895, 1992.
5. Rich S: Primary Pulmonary Hypertension: Executive Summary from the World Symposium on Primary Pulmonary Hypertension 1998, Evian, France, September 6-10, 1998. Co-sponsored by World Health Organization.
6. Enriquez-Sarano M, Rossi A, Seward JB, et al: Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 29: 153-159, 1997.
7. Rabinovitch M: Pulmonary hypertension: Pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 18: 1041-1053, 1999.
8. Galie N, Manes A, Uguccioni L, et al: Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest 114: 1845-1945, 1998.
9. Butler J, Chomsky DB, Wilson JR: Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34: 1802-1806, 1999.
10. Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19: 48-54, 1992.
11. Murali S, Uretsky BF, Armitage JM, et al: Utility of prostaglandin E1 in the retransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 11: 716-723, 1992.
12. Semigran MJ, Cockrill BA, Kacmarek R, et al: Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 24: 982-988, 1994.
13. Givertz MM, Hare JM, Loh E, et al: Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: A rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 28: 1775-1780, 1996.
14. Murali S, Uretsky BF, Reddy PS, et al: Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 122: 1375-1381, 1991.
15. Addonizio LJ, Gersony WM, Robbins RC, et al: Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 76: V52-V55, 1987.
16. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, et al: Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant 9: 526-537, 1990.
17. Nakatani T, Frazier OH, Lammermeier DE, et al: Heterotopic heart transplantation: a reliable option for a select group of high-risk patients. J Heart Transplant 8: 40-47, 1989.
18. Bleasdale RA, Banner NR, Anyanwu AC, et al: Determinants of outcome after heterotopic heart transplantation. J Heart Lung Transplant 21: 867-873, 2002.
19. Reichenspurner H, Hildebrandt A, Boehm D, et al: Heterotopic heart transplantation in 1988-Recent selective indications and outcome. J Heart Transplants: 381-386, 1989.
20. Anyanwu AC, Banner NR, Radley-Smith R, et al: Long-term results of cardiac transplantation from live donors: the domino heart transplant. J Heart Lung Transplant 21: 971-975, 2002.
21. Kawagauchi A: et al: Cardiac transplant recipients with preoperative pulmonary hypertension. Evolution of pulmonary hemodynamics and surgical options. Circulation 80: III90-III96, 1989.
22. Gallagher RC, Kormos RL, Gasior T, et al: Univentricular support results in reduction of pulmonary resistance and improved right ventricular function. ASAIO Trans 37: M287-M288, 1991.
23. Baldovinos A, Kalangos A, Sierra J, et al: Is partially reversible pulmonary hypertension a contraindication for heart transplantation? Transplant Proc 32: 468-469, 2000.
24. Smedira NG, Massad MG, Navia J, et al: Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system support. ASAIO J 42: M733-M735, 1996.
25. Adamson RM, Dembitsky WP, Jaski BE, et al: Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency. ASAIO J 43: 365-369, 1997.
26. Nguyen DQ, Ormaza S, Miller LW, et al: Left ventricular assist device support for medically unresponsive pulmonary hypertension from left ventricular failure [abstract]. J Heart Lung Transplant 20: 190, 2001.
27. Petrofski JA, Hoopes CW, Bashore TM, et al: Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congenital heart disease. Ann Thorac Surg 75: 1005-1007, 2003.
28. Al-Khaldi A, Ergina P, DeVarennes B, et al: Left ventricular unloading in a patient with end-stage cardiomyopathy and medically unresponsive pulmonary hypertension. Artif Organs 28: 158-160, 2004.
29. Martin J, Siegenthaler MP, Friesewinkel O, et al: Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 25: 971-977, 2004.
30. Piccione W Jr: Left ventricular assist device implantation: Short and long-term surgical complications. J Heart Lung Transplant 19: 589-94, 2000.
31. Digiorgi PL, Reel MS, Thornton B, et al: Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 24: 200-204, 2005.
32. Moskowitz AJ, Rose EA, Gelijns AC: The cost of long-term LVAD implantation. Ann Thorac Surg 71: 5195-5198; discussion 5203-204, 2001.
33. Oz MC, Argenziano M, Catanese KA, et al: Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 95: 1844-1852, 1997.
34. Eric AR, Annetine CG, Alan JM, et al: for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.